Athenex Announces Additional Licensing Agreements for Tirbanibulin

Ads

You May Also Like

Precision Therapeutics Reports Second Quarter 2018 Financial Results

Helomics Holding Corporation, predicted to generate approximately $3.2 million in revenues by the end ...

Diffusion Pharmaceuticals Announces Publication of RES-529 Review Article in Anti-Cancer Drugs

CHARLOTTESVILLE, Va., March 15, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical ...